{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T17:21:00Z","timestamp":1790356860613,"version":"4.1.0"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,24]],"date-time":"2024-12-24T00:00:00Z","timestamp":1734998400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.phrs.2024.107567","type":"journal-article","created":{"date-parts":[[2024,12,25]],"date-time":"2024-12-25T07:13:59Z","timestamp":1735110839000},"page":"107567","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["LIX1L aggravates MASH-HCC progression by reprogramming of hepatic metabolism and microenvironment via CD36"],"prefix":"10.1016","volume":"211","author":[{"given":"Yingrong","family":"Leng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanqiu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengtao","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengmeng","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enyi","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingyi","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.phrs.2024.107567_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2020.154170","article-title":"Complications, morbidity and mortality of nonalcoholic fatty liver disease","volume":"111","author":"Mantovani","year":"2020","journal-title":"Metabolism"},{"issue":"8","key":"10.1016\/j.phrs.2024.107567_bib2","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1016\/j.cgh.2023.03.041","article-title":"Clinical trial landscape in NASH","volume":"21","author":"Harrison","year":"2023","journal-title":"Clin. Gastroenterol. H."},{"issue":"8","key":"10.1016\/j.phrs.2024.107567_bib3","first-page":"724","article-title":"Emerging mechanisms of non-alcoholic steatohepatitis and novel drug therapies","volume":"22","author":"Chen","year":"2024","journal-title":"Chin. J. Nat. Med."},{"issue":"4","key":"10.1016\/j.phrs.2024.107567_bib4","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1111\/cas.15687","article-title":"Limb expression 1-like protein promotes epithelial-mesenchymal transition and epidermal growth factor receptor-tyrosine kinase inhibitor resistance via nucleolin-mediated ribosomal RNA synthesis in non-small cell lung cancer","volume":"114","author":"Li","year":"2023","journal-title":"Cancer Sci."},{"key":"10.1016\/j.phrs.2024.107567_bib5","doi-asserted-by":"crossref","first-page":"13474","DOI":"10.1038\/srep13474","article-title":"Novel roles for LIX1L in promoting cancer cell proliferation through ROS1-mediated LIX1L phosphorylation","volume":"5","author":"Nakamura","year":"2015","journal-title":"Sci. Rep."},{"issue":"11","key":"10.1016\/j.phrs.2024.107567_bib6","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0028011","article-title":"Transcriptional repression of Cdc25B by IER5 inhibits the proliferation of leukemic progenitor cells through NF-YB and p300 in acute myeloid leukemia","volume":"6","author":"Nakamura","year":"2011","journal-title":"PloS One"},{"issue":"6","key":"10.1016\/j.phrs.2024.107567_bib7","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1016\/j.apsb.2021.02.005","article-title":"LIX1-like protein promotes liver cancer progression miR-21-3p-mediated inhibition of fructose-1,6-bisphosphatase","volume":"11","author":"Zou","year":"2021","journal-title":"Acta Pharm. Sin. B."},{"issue":"2","key":"10.1016\/j.phrs.2024.107567_bib8","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.jhep.2021.02.035","article-title":"Limb expression 1-like (LIX1L) protein promotes cholestatic liver injury by regulating bile acid metabolism","volume":"75","author":"Li","year":"2021","journal-title":"J. Hepatol."},{"issue":"1","key":"10.1016\/j.phrs.2024.107567_bib9","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/s41392-021-00665-6","article-title":"LIX1-like protein drives hepatic stellate cell activation to promote liver fibrosis by regulation of chemokine mRNA stability","volume":"6","author":"Zhu","year":"2021","journal-title":"Signal Transduct. Tar."},{"issue":"4","key":"10.1016\/j.phrs.2024.107567_bib10","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1016\/j.jhep.2022.06.012","article-title":"Immune mechanisms linking metabolic injury to inflammation and fibrosis in fatty liver disease - novel insights into cellular communication circuits","volume":"77","author":"Peiseler","year":"2022","journal-title":"J. Hepatol."},{"key":"10.1016\/j.phrs.2024.107567_bib11","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1146\/annurev.nutr.22.020402.130846","article-title":"Fatty acid transport across membranes: relevance to nutrition and metabolic pathology","volume":"22","author":"Hajri","year":"2002","journal-title":"Annu Rev. Nutr."},{"issue":"10","key":"10.1016\/j.phrs.2024.107567_bib12","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1136\/gut.2010.222844","article-title":"Hepatic fatty acid translocase CD36 upregulation is associated with insulin resistance, hyperinsulinaemia and increased steatosis in non-alcoholic steatohepatitis and chronic hepatitis C","volume":"60","author":"Miquilena-Colina","year":"2011","journal-title":"Gut"},{"issue":"7","key":"10.1016\/j.phrs.2024.107567_bib13","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2010.02.051","article-title":"Role of scavenger receptor A and CD36 in diet-induced nonalcoholic steatohepatitis in hyperlipidemic mice","volume":"138","author":"Bieghs","year":"2010","journal-title":"Gastroenterology"},{"issue":"10","key":"10.1016\/j.phrs.2024.107567_bib14","doi-asserted-by":"crossref","first-page":"4329","DOI":"10.1172\/JCI99315","article-title":"Endothelial cell CD36 optimizes tissue fatty acid uptake","volume":"128","author":"Son","year":"2018","journal-title":"J. Clin. Invest"},{"issue":"7","key":"10.1016\/j.phrs.2024.107567_bib15","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1016\/j.immuni.2021.05.003","article-title":"Uptake of oxidized lipids by the scavenger receptor CD36 promotes lipid peroxidation and dysfunction in CD8 T cells in tumors","volume":"54","author":"Xu","year":"2021","journal-title":"Immunity"},{"issue":"13","key":"10.1016\/j.phrs.2024.107567_bib16","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1038\/s41388-024-02960-2","article-title":"Crosstalk between endothelial progenitor cells and HCC through periostin\/CCL2\/CD36 supports formation of the pro-metastatic microenvironment in HCC","volume":"43","author":"Deng","year":"2024","journal-title":"Oncogene"},{"issue":"11","key":"10.1016\/j.phrs.2024.107567_bib17","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1016\/j.cmet.2023.09.012","article-title":"CD36 maintains lipid homeostasis via selective uptake of monounsaturated fatty acids during matrix detachment and tumor progression","volume":"35","author":"Terry","year":"2023","journal-title":"Cell Metab."},{"issue":"1","key":"10.1016\/j.phrs.2024.107567_bib18","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1186\/s13045-021-01200-4","article-title":"Contradictory roles of lipid metabolism in immune response within the tumor microenvironment","volume":"14","author":"Yu","year":"2021","journal-title":"J. Hematol. Oncol."},{"issue":"2","key":"10.1016\/j.phrs.2024.107567_bib19","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.jhep.2017.10.031","article-title":"Preclinical models of non-alcoholic fatty liver disease","volume":"68","author":"Santhekadur","year":"2018","journal-title":"J. Hepatol."},{"issue":"9","key":"10.1016\/j.phrs.2024.107567_bib20","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1016\/j.cmet.2022.07.010","article-title":"Neuregulin 4 suppresses NASH-HCC development by restraining tumor-prone liver microenvironment","volume":"34","author":"Zhang","year":"2022","journal-title":"Cell Metab."},{"issue":"4","key":"10.1016\/j.phrs.2024.107567_bib21","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/nmeth.3317","article-title":"HISAT: a fast spliced aligner with low memory requirements","volume":"12","author":"Kim","year":"2015","journal-title":"Nat. Methods"},{"issue":"3","key":"10.1016\/j.phrs.2024.107567_bib22","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/nbt.3122","article-title":"StringTie enables improved reconstruction of a transcriptome from RNA-seq reads","volume":"33","author":"Pertea","year":"2015","journal-title":"Nat. Biotechnol."},{"issue":"24","key":"10.1016\/j.phrs.2024.107567_bib23","doi-asserted-by":"crossref","first-page":"15791","DOI":"10.3390\/ijms232415791","article-title":"Genetic and diet-induced animal models for non-alcoholic fatty liver disease (NAFLD) research","volume":"23","author":"Flessa","year":"2022","journal-title":"Int J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.phrs.2024.107567_bib24","doi-asserted-by":"crossref","first-page":"4084","DOI":"10.1038\/s41467-023-39404-6","article-title":"Liver lipophagy ameliorates nonalcoholic steatohepatitis through extracellular lipid secretion","volume":"14","author":"Minami","year":"2023","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.phrs.2024.107567_bib25","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/nrendo.2016.135","article-title":"PPARs in obesity-induced T2DM, dyslipidaemia and NAFLD","volume":"13","author":"Gross","year":"2017","journal-title":"Nat. Rev. Endocrinol."},{"issue":"3","key":"10.1016\/j.phrs.2024.107567_bib26","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1038\/nchembio.2568","article-title":"Insights into the biogenesis, function, and regulation of ADP-ribosylation","volume":"14","author":"Cohen","year":"2018","journal-title":"Nat. Chem. Biol."},{"issue":"14","key":"10.1016\/j.phrs.2024.107567_bib27","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.1016\/j.molcel.2022.04.031","article-title":"A PARylation-phosphorylation cascade promotes TOPBP1 loading and RPA-RAD51 exchange in homologous recombination","volume":"82","author":"Zhao","year":"2022","journal-title":"Mol. Cell"},{"issue":"22","key":"10.1016\/j.phrs.2024.107567_bib28","doi-asserted-by":"crossref","first-page":"4591","DOI":"10.1016\/j.molcel.2021.09.006","article-title":"Noncanonical mono(ADP-ribosyl)ation of zinc finger SZF proteins counteracts ubiquitination for protein homeostasis in plant immunity","volume":"81","author":"Kong","year":"2021","journal-title":"Mol. Cell"},{"key":"10.1016\/j.phrs.2024.107567_bib29","article-title":"Apigenin inhibits STAT3\/CD36 signaling axis and reduces visceral obesity","volume":"152","author":"Su","year":"2023","journal-title":"Pharm. Res"},{"issue":"1","key":"10.1016\/j.phrs.2024.107567_bib30","doi-asserted-by":"crossref","first-page":"5782","DOI":"10.1038\/s41467-022-33349-y","article-title":"CD36-mediated metabolic crosstalk between tumor cells and macrophages affects liver metastasis","volume":"13","author":"Yang","year":"2022","journal-title":"Nat. Commun."},{"issue":"5","key":"10.1016\/j.phrs.2024.107567_bib31","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/j.cmet.2021.02.015","article-title":"CD36-mediated ferroptosis dampens intratumoral CD8(+) T cell effector function and impairs their antitumor ability","volume":"33","author":"Ma","year":"2021","journal-title":"Cell Metab."},{"issue":"3","key":"10.1016\/j.phrs.2024.107567_bib32","first-page":"1026","article-title":"The role of innate immune cells in nonalcoholic steatohepatitis","volume":"70","author":"Cai","year":"2019"},{"issue":"6","key":"10.1016\/j.phrs.2024.107567_bib33","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1016\/j.jhep.2021.07.032","article-title":"Regulatory T-cell and neutrophil extracellular trap interaction contributes to carcinogenesis in non-alcoholic steatohepatitis","volume":"75","author":"Wang","year":"2021","journal-title":"J. Hepatol."},{"key":"10.1016\/j.phrs.2024.107567_bib34","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.655697","article-title":"Hepatocellular carcinoma immune landscape and the potential of immunotherapies","volume":"12","author":"Giraud","year":"2021","journal-title":"Front Immunol."},{"issue":"5","key":"10.1016\/j.phrs.2024.107567_bib35","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1002\/hep.32707","article-title":"Profiling of syngeneic mouse HCC tumor models as a framework to understand anti-PD-1 sensitive tumor microenvironments","volume":"77","author":"Zabransky","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.phrs.2024.107567_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115131","article-title":"State of CD8+T cells in progression from nonalcoholic steatohepatitis to hepatocellular carcinoma: from pathogenesis to immunotherapy","volume":"165","author":"Zhong","year":"2023","journal-title":"Biomed. Pharm."},{"issue":"7854","key":"10.1016\/j.phrs.2024.107567_bib37","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/s41586-021-03362-0","article-title":"NASH limits anti-tumour surveillance in immunotherapy-treated HCC","volume":"592","author":"Pfister","year":"2021","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.phrs.2024.107567_bib38","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.tem.2008.11.005","article-title":"New developments in adipogenesis","volume":"20","author":"Lefterova","year":"2009","journal-title":"Trends Endocrin Met"},{"issue":"5","key":"10.1016\/j.phrs.2024.107567_bib39","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1177\/1535370215619041","article-title":"The increasingly complex regulation of adipocyte differentiation","volume":"241","author":"Poulos","year":"2016","journal-title":"Exp. Biol. Med."},{"issue":"3","key":"10.1016\/j.phrs.2024.107567_bib40","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.molcel.2019.07.028","article-title":"Landscape of intercellular crosstalk in healthy and NASH liver revealed by single-cell secretome gene analysis","volume":"75","author":"Xiong","year":"2019","journal-title":"Mol. Cell"},{"issue":"3","key":"10.1016\/j.phrs.2024.107567_bib41","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.immuni.2020.08.004","article-title":"Osteopontin expression identifies a subset of recruited macrophages distinct from kupffer cells in the fatty liver","volume":"53","author":"Remmerie","year":"2020","journal-title":"Immunity"},{"issue":"2","key":"10.1016\/j.phrs.2024.107567_bib42","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/s41575-019-0210-2","article-title":"Adaptive immunity: an emerging player in the progression of NAFLD","volume":"17","author":"Sutti","year":"2020","journal-title":"Nat. Rev. Gastro Hepat."},{"issue":"9","key":"10.1016\/j.phrs.2024.107567_bib43","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1016\/j.immuni.2021.08.006","article-title":"A subset of Kupffer cells regulates metabolism through the expression of CD36","volume":"54","author":"Bl\u00e9riot","year":"2021","journal-title":"Immunity"},{"issue":"2","key":"10.1016\/j.phrs.2024.107567_bib44","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1002\/hep4.1807","article-title":"The detrimental role of regulatory T cells in nonalcoholic steatohepatitis","volume":"6","author":"Dywicki","year":"2022","journal-title":"Hepatol. Commun."},{"issue":"8","key":"10.1016\/j.phrs.2024.107567_bib45","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/s41575-023-00754-7","article-title":"Nonalcoholic steatohepatitis-related hepatocellular carcinoma: pathogenesis and treatment","volume":"20","author":"Llovet","year":"2023","journal-title":"Nat. Rev. Gastro Hepat."},{"key":"10.1016\/j.phrs.2024.107567_bib46","doi-asserted-by":"crossref","first-page":"5214","DOI":"10.1038\/s41467-018-07402-8","article-title":"An inflammatory-CCRK circuitry drives mTORC1-dependent metabolic and immunosuppressive reprogramming in obesity-associated hepatocellular carcinoma","volume":"9","author":"Sun","year":"2018","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.phrs.2024.107567_bib47","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/s41421-023-00529-z","article-title":"CD36 cancer-associated fibroblasts provide immunosuppressive microenvironment for hepatocellular carcinoma via secretion of macrophage migration inhibitory factor","volume":"9","author":"Zhu","year":"2023","journal-title":"Cell Discov."},{"issue":"10","key":"10.1016\/j.phrs.2024.107567_bib48","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2017.1344804","article-title":"Exogenous lipid uptake induces metabolic and functional reprogramming of tumor-associated myeloid-derived suppressor cells","volume":"6","author":"Al-Khami","year":"2017","journal-title":"Oncoimmunology"},{"issue":"3","key":"10.1016\/j.phrs.2024.107567_bib49","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.jhep.2016.10.023","article-title":"PARP inhibition protects against alcoholic and non-alcoholic steatohepatitis","volume":"66","author":"Mukhopadhyay","year":"2017","journal-title":"J. Hepatol."},{"issue":"5","key":"10.1016\/j.phrs.2024.107567_bib50","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/j.jhep.2016.11.020","article-title":"PARP1-mediated PPAR\u03b1 poly(ADP-ribosyl)ation suppresses fatty acid oxidation in non-alcoholic fatty liver disease","volume":"66","author":"Huang","year":"2017","journal-title":"J. Hepatol."},{"issue":"1","key":"10.1016\/j.phrs.2024.107567_bib51","doi-asserted-by":"crossref","first-page":"9","DOI":"10.14348\/molcells.2014.2245","article-title":"ADP-ribosylation: activation, recognition, and removal","volume":"37","author":"Li","year":"2014","journal-title":"Mol. Cells"},{"issue":"10","key":"10.1016\/j.phrs.2024.107567_bib52","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/S1470-2045(18)30494-7","article-title":"TOMAS: revisiting PARP inhibitor combination therapy","volume":"19","author":"Nacev","year":"2018","journal-title":"Lancet Oncol."},{"issue":"6","key":"10.1016\/j.phrs.2024.107567_bib53","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1158\/0008-5472.CAN-21-2997","article-title":"ATR Inhibitor AZD6738 (Ceralasertib) exerts antitumor activity as a monotherapy and in combination with chemotherapy and the PARP inhibitor olaparib","volume":"82","author":"Wilson","year":"2022","journal-title":"Cancer Res."}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661824005127?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661824005127?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T13:49:55Z","timestamp":1736430595000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661824005127"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":53,"alternative-id":["S1043661824005127"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2024.107567","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"LIX1L aggravates MASH-HCC progression by reprogramming of hepatic metabolism and microenvironment via CD36","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2024.107567","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"107567"}}